<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30214216</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Print">1176-6336</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>14</Volume>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>Therapeutics and clinical risk management</Title>                <ISOAbbreviation>Ther Clin Risk Manag</ISOAbbreviation>            </Journal>            <ArticleTitle>Diagnostic value of PD-1 mRNA expression combined with breast ultrasound in breast cancer patients.</ArticleTitle>            <Pagination>                <MedlinePgn>1527-1535</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.2147/TCRM.S168531</ELocationID>            <Abstract>                <AbstractText Label="Introduction" NlmCategory="UNASSIGNED">This study explored the value of measuring programmed death 1 (PD-1) in peripheral blood, combined with breast ultrasound using the Breast Imaging Reporting and Data System (BI-RADS) classification, for differentiation between benign and malignant breast tumors.</AbstractText>                <AbstractText Label="Materials and methods" NlmCategory="UNASSIGNED">We enrolled 113 patients with breast cancer and 66 patients with benign breast tumors who were admitted to Hangzhou First People's Hospital from September 2014 to August 2017. The mRNA level of PD-1 was detected by quantitative real-time polymerase chain reaction.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">The mRNA levels of PD-1 were significantly higher in the peripheral blood of patients with breast cancer than those in patients with benign breast tumors. The diagnostic sensitivity of PD-1 mRNA expression was 0.805, the specificity was 0.788, and the area under the curve (AUC) was 0.848 (<i>P</i> &lt; 0.001); the sensitivity of breast ultrasound-based BI-RADS classification was 0.752, the specificity was 0.909, and the AUC was 0.906 (<i>P</i> &lt; 0.001); and the combined sensitivity, specificity, and AUC of the two assays were 0.920, 0.879, and 0.938, respectively (<i>P</i> &lt; 0.001). Progesterone receptor-positive breast cancer patients exhibited high levels of PD-1 expression (<i>P</i> &lt; 0.001).</AbstractText>                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">This study suggests that the measurement of PD-1 combined with breast ultrasound-based BI-RADS classification represents a significant improvement for breast cancer diagnosis compared with diagnoses based on either method alone.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Fang</LastName>                    <ForeName>Jianhua</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Ultrasonography, Hangzhou First People's Hospital, Hangzhou 310006, People's Republic of China, baolingyun976@sina.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shao</LastName>                    <ForeName>Yi</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Ophthalmology, The First Affiliated Hospital of Nanchang University, Nanchang 330006, People's Republic of China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Su</LastName>                    <ForeName>Jiezhi</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast and Chest Surgery, The First Affiliated Hospital of Hainan Medical University, Haikou 570102, People's Republic of China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wan</LastName>                    <ForeName>Ying</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Ultrasound, The First Affiliated Hospital of Hainan Medical University, Haikou 570102, People's Republic of China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bao</LastName>                    <ForeName>Lingyun</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Ultrasonography, Hangzhou First People's Hospital, Hangzhou 310006, People's Republic of China, baolingyun976@sina.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wang</LastName>                    <ForeName>Wei</ForeName>                    <Initials>W</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Ultrasonography, Hangzhou First People's Hospital, Hangzhou 310006, People's Republic of China, baolingyun976@sina.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kong</LastName>                    <ForeName>Fanlei</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Ultrasonography, Hangzhou First People's Hospital, Hangzhou 310006, People's Republic of China, baolingyun976@sina.com.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>28</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>New Zealand</Country>            <MedlineTA>Ther Clin Risk Manag</MedlineTA>            <NlmUniqueID>101253281</NlmUniqueID>            <ISSNLinking>1176-6336</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2013 Jun;139(3):667-76</RefSource>                <PMID Version="1">23756627</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2014 Jun;15(7):e279-89</RefSource>                <PMID Version="1">24872111</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2013 Aug 15;19(16):4477-87</RefSource>                <PMID Version="1">23797906</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Oncol. 2016 Apr;23(2):e131-7</RefSource>                <PMID Version="1">27122981</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2017 Jan 1;123(2):219-227</RefSource>                <PMID Version="1">27683209</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lung Cancer. 2016 Sep;99:4-10</RefSource>                <PMID Version="1">27565906</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Radiol. 2016 Oct;85(10):1701-1707</RefSource>                <PMID Version="1">27666605</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2011 Dec;130(3):819-23</RefSource>                <PMID Version="1">21748292</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiol Clin North Am. 2014 May;52(3):481-7</RefSource>                <PMID Version="1">24792650</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncoimmunology. 2017 Feb 6;6(2):e1253654</RefSource>                <PMID Version="1">28344865</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Histopathology. 2016 Jul;69(1):25-34</RefSource>                <PMID Version="1">26588661</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2017 Feb;162(1):19-30</RefSource>                <PMID Version="1">28058578</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Sci. 2014 Oct;105(10):1229-35</RefSource>                <PMID Version="1">25117757</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Tumour Biol. 2014 Nov;35(11):11533-40</RefSource>                <PMID Version="1">25129439</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2012 Jul 10;107(2):224-9</RefSource>                <PMID Version="1">22691969</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Jpn J Clin Oncol. 2015 May;45(5):411-5</RefSource>                <PMID Version="1">25670765</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Immunol Rev. 2009 May;229(1):126-44</RefSource>                <PMID Version="1">19426219</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2016 Dec 19;18(1):129</RefSource>                <PMID Version="1">27993161</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Hematol Oncol. 2017 Apr 28;10(1):98</RefSource>                <PMID Version="1">28454587</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lung Cancer. 2016 Oct;100:77-84</RefSource>                <PMID Version="1">27597284</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2016 Apr 27;18(1):43</RefSource>                <PMID Version="1">27117582</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Treat Rev. 2016 May;46:9-19</RefSource>                <PMID Version="1">27055087</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Biomed Eng. 2018 Sep;46(9):1419-1431</RefSource>                <PMID Version="1">29748869</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur Radiol. 2017 Jun;27(6):2443-2450</RefSource>                <PMID Version="1">27761708</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Breast Cancer. 2017 Mar;20(1):12-19</RefSource>                <PMID Version="1">28382090</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncol Rep. 2009 Nov;22(5):1119-27</RefSource>                <PMID Version="1">19787229</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Surg Oncol. 2018 May;117(6):1131-1136</RefSource>                <PMID Version="1">29193094</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2015 Nov;154(2):423-34</RefSource>                <PMID Version="1">26476723</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2014 May 15;20(10):2773-82</RefSource>                <PMID Version="1">24647569</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Lett. 2015 Dec 1;369(1):67-75</RefSource>                <PMID Version="1">26276721</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2016 Jul 1;22(13):3249-59</RefSource>                <PMID Version="1">26842237</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2014 Feb;23(1):88-93</RefSource>                <PMID Version="1">24291374</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Invest. 2014 May;124(5):2246-59</RefSource>                <PMID Version="1">24667641</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Immunol Res. 2014 Apr;2(4):320-31</RefSource>                <PMID Version="1">24764579</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Immunol Immunother. 2014 Apr;63(4):395-406</RefSource>                <PMID Version="1">24514954</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29</RefSource>                <PMID Version="1">25559415</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Feb 21;8(8):13855-13862</RefSource>                <PMID Version="1">28099938</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Onco Targets Ther. 2016 Feb 24;9:911-9</RefSource>                <PMID Version="1">26966379</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Immunol Res. 2016 Jan;4(1):41-8</RefSource>                <PMID Version="1">26546451</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncoimmunology. 2015 Aug 31;5(3):e1085148</RefSource>                <PMID Version="1">27141340</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2016 May 19;16:320</RefSource>                <PMID Version="1">27198767</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2015 Jun 25;372(26):2509-20</RefSource>                <PMID Version="1">26028255</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Immunol Immunother. 2015 Jul;64(7):853-60</RefSource>                <PMID Version="1">25893809</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2016 Sep 16;11(9):e0163030</RefSource>                <PMID Version="1">27636552</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Feb 7;8(6):9230-9242</RefSource>                <PMID Version="1">27999208</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiother Oncol. 2017 Sep;124(3):403-410</RefSource>                <PMID Version="1">28579282</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Onco Targets Ther. 2016 Jul 27;9:4653-60</RefSource>                <PMID Version="1">27536129</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ultrasound Med Biol. 2015 Jan;41(1):47-55</RefSource>                <PMID Version="1">25479813</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiology. 2018 Jul;288(1):26-35</RefSource>                <PMID Version="1">29714680</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiology. 2017 Feb;282(2):348-355</RefSource>                <PMID Version="1">27598536</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">PD-1</Keyword>            <Keyword MajorTopicYN="N">breast cancer</Keyword>            <Keyword MajorTopicYN="N">breast ultrasound</Keyword>            <Keyword MajorTopicYN="N">diagnosis</Keyword>        </KeywordList>        <CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>15</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>15</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>15</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30214216</ArticleId>            <ArticleId IdType="doi">10.2147/TCRM.S168531</ArticleId>            <ArticleId IdType="pii">tcrm-14-1527</ArticleId>            <ArticleId IdType="pmc">PMC6118870</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>